The prevention of isoproterenol desensitization and isoproterenol reversal.
D000628:Aminophylline / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects*; D001966:Bromine / Q000494:pharmacology; D003888:Desensitization, Immunologic; D004347:Drug Interactions; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013618:Tachyphylaxis / Q000187:drug effects*; D013748:Tetracaine / Q000494:pharmacology; D013805:Theobromine / Q000494:pharmacology; D014132:Trachea / Q000187:drug effects
D011941:Receptors, Adrenergic; D013748:Tetracaine; D000804:Angiotensin II; D000628:Aminophylline; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D010208:Papaverine; D005996:Nitroglycerin; D007545:Isoproterenol; D013805:Theobromine; D001966:Bromine; D009638:Norepinephrine; D010646:Phentolamine